Wells Fargo analyst issues EQUAL-WEIGHT recommendation for NOVA on August 6, 2024 06:20AM ET. The previous analyst recommendation was Equal-Weight.NOVA was trading at $7.71 at issue of the analyst recommendation.The...
Barclays analyst issues OVERWEIGHT recommendation for CVX on August 6, 2024 05:36AM ET. The previous analyst recommendation was Overweight.CVX was trading at $144.66 at issue of the analyst recommendation.The overall...
RBC Capital analyst issues OUTPERFORM recommendation for CVX on August 5, 2024 08:43AM ET. The previous analyst recommendation was Outperform.CVX was trading at $148.55 at issue of the analyst recommendation.The...
UBS analyst issues BUY recommendation for XOM on August 5, 2024 08:41AM ET. The previous analyst recommendation was Buy.XOM was trading at $116.88 at issue of the analyst recommendation.The overall...
Susquehanna analyst issues POSITIVE recommendation for EOG on August 5, 2024 07:03AM ET. The previous analyst recommendation was Positive.EOG was trading at $122.92 at issue of the analyst recommendation.The overall...
Barclays analyst issues EQUAL-WEIGHT recommendation for PSX on August 5, 2024 05:52AM ET. The previous analyst recommendation was Equal-Weight.PSX was trading at $133.76 at issue of the analyst recommendation.The overall...
Barclays analyst issues OVERWEIGHT recommendation for SHEL on August 2, 2024 05:05PM ET. The previous analyst recommendation was Overweight.SHEL was trading at $71.68 at issue of the analyst recommendation.The overall...
TD Securities analyst issues BUY recommendation for CNQ on August 2, 2024 11:36AM ET. The previous analyst recommendation was Buy.CNQ was trading at $33.18 at issue of the analyst recommendation.The...
Scotiabank analyst issues OUTPERFORM recommendation for TRP on August 2, 2024 11:48AM ET. The previous analyst recommendation was Outperform.TRP was trading at $42.94 at issue of the analyst recommendation.The overall...
National Bank analyst issues OUTPERFORM recommendation for CVE on August 2, 2024 11:52AM ET. The previous analyst recommendation was Outperform.CVE was trading at $17.9301 at issue of the analyst recommendation.The...
